TAG:
laboratory compliance
Docs’ In-Office Testing Showing Mixed Trends
By Robert Michel | From the Volume IX No. 17 – December 9, 2002 Issue
CEO SUMMARY: Despite the burdens of CLIA certification and reduced reimbursement for lab tests, many medical practice experts are advising doctors to expand in-office testing. However, diagnostic technologies for near-patient testing are still not robust enough to support this trend. Earl…
Patient Safety is Related to “Quality Management”
By R. Lewis Dark | From the Volume IX No. 17 – December 9, 2002 Issue
REMEMBER BACK IN 1997 WHEN LABORATORY COMPLIANCE PROGRAMS were mandated by Medicare officials? That was a big thing in the laboratory industry. Every laboratory organization in the United States scrambled to assess their laboratory’s operating practices, develop policies, and create a compliance ma…
Time to Change Bad Medicare Lab Policies
By R. Lewis Dark | From the Volume VIII No. 6 – April 30, 2001 Issue
BYZANTINE MEDICARE REGULATIONS AND BELTWAY POLITICS are uncommon topics for THE DARK REPORT. There are any number of other sources out there that provide ample details about laboratory compliance, the complexities of billing and coding, and whether Senator Smootly will or won’t vote for reinstating…
Year’s Ten Biggest Stories Reveal Modest Changes
By Robert Michel | From the Volume VII No. 17 – December 4, 2000 Issue
CEO SUMMARY: In many ways, 2000 was a relatively quiet year for laboratory organizations. This list of the ten biggest stories in the lab industry for 2000 demonstrates that the most innovative laboratory organizations in the United States are “raising the bar” for service and quality…
Is it Early-90s “Deja Vu” For Today’s Lab Industry?
By Robert Michel | From the Volume VII No. 14 – October 2, 2000 Issue
CEO SUMMARY: Stock prices for laboratory and pathology companies have skyrocketed since the new decade of the 2000s dawned on January 1. Is investor optimism warranted by the opportunities ahead in diagnostic testing? Or will history repeat itself if the continuing evolution of American h…
“State of Lab Industry” Holds Surprises for All
By Robert Michel | From the Volume VII No. 1 – January 3, 2000 Issue
CEO SUMMARY: Say goodbye to several of the trends which shaped the lab industry during the 1990s, such as consolidation and government compliance programs. Although these trends won’t completely disappear, they will be superseded by a number of new transformational influences. During th…
1999’s Top Ten Stories Reflect Speed of Change
By Robert Michel | From the Volume VI No. 17 – December 13, 1999 Issue
CEO SUMMARY: This year’s round-up of the lab industry’s Top Ten most important stories lacks any compelling single theme. THE DARK REPORT’s conclusion? 1999 was a transition year. No new outside forces rattled the lab industry, allowing lab executives and pathologists to concentrate…
Healtheon Already Choice Of Public Lab Companies
By Robert Michel | From the Volume VI No. 15 – November 1, 1999 Issue
CEO SUMMARY: Probably no single individual has greater insight about the changes now occurring to web-based laboratory test ordering and results reporting than Healtheon Corporation’s Nancy Ham. As Vice President of Connectivity & Institutional Services, Nancy is responsible for Hea…
FDA Wants Abbott Labs To Toe Regulatory Line
By Robert Michel | From the Volume VI No. 14 – October 11, 1999 Issue
CEO SUMMARY: In the short term, it’s Abbott Laboratories which must deal with increasingly aggressive FDA regulators. But the real story behind the story is that the FDA is stepping up regulatory oversight of the entire diagnostics industry. Abbott faces serious consequences if it canno…
Pathologist Income Symposium, Healtheon, Biogenetics, Healthworks Alliance
By Robert Michel | From the Volume VI No. 13 – September 20, 1999 Issue
PATHOLOGIST INCOME SYMPOSIUM DATES ARE NOVEMBER 12-13, 1999 SCOTTSDALE IS AGAIN SLATED TO HOST the upcoming private Pathologist Income Symposium, scheduled for November 12-13, 1999. This year’s symposium tackles the toughest of all topics: increasing the compensation paid by hosp…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized